# Anakinra for Inflammatory Pustular Skin Diseases

> **NCT01794117** · PHASE2 · COMPLETED · sponsor: **National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)** · enrollment: 18 (actual)

## Conditions studied

- Sneddon-Wilkinson
- Acrodermatitis Continua of Hallopeau
- Pustular Psoriasis
- Palmoplantar Pustulosis

## Interventions

- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT01794117
- **Lead sponsor:** National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-22
- **Primary completion:** 2019-03-19
- **Final completion:** 2019-10-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01794117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01794117, "Anakinra for Inflammatory Pustular Skin Diseases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01794117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*